UCSF’s Converge initiative and similar accelerators are transforming how health systems deploy AI, challenging legacy EHR vendors and speeding up clinical innovation.
Inside-out AI accelerators like UCSF’s Converge are rewriting the rules of healthcare technology procurement.
The Rise of Inside-Out AI in Healthcare
In 2024, UCSF Health launched Converge, an AI accelerator that pairs startups with clinicians to develop solutions from within the health system. This ‘inside-out’ model is gaining traction as traditional EHR vendors—Epic, Cerner, Meditech—struggle with interoperability and customization. ‘We realized that the best way to solve clinical pain points is to build with clinicians, not for them,’ said Dr. Michael Blum, associate director of UCSF’s Center for Digital Health Innovation, in a press release. Converge provides institutional credibility and capital, with backing from Kleiner Perkins, a leading venture capital firm. Within its first year, the accelerator has launched five startups focusing on patient navigation and clinical documentation.
Measuring the Impact: Data and Outcomes
Recent data underscores the momentum. According to a KLAS Research report from February 2025, 67% of health systems plan to increase AI procurement via accelerators in 2025, up from 34% in 2023. The shift is driven by measurable gains: Mass General Brigham’s AI accelerator reduced prior authorization processing time by 30% in pilot programs. Similarly, a JAMA Network study published in March 2025 found that AI-powered patient navigation improved no-show rates by 22%. These results are prompting health systems to view accelerators as a strategic imperative rather than an experiment.
Forcing EHR Giants to Adapt or Partner
Traditional EHR vendors are responding. Epic Systems has launched its own AI interoperability framework, while Oracle Cerner announced partnerships with startup aggregators. ‘The accelerators are forcing us to rethink our innovation cycle,’ said a senior product manager at Epic, speaking on condition of anonymity. However, some experts warn of fragmentation. ‘Without shared standards, we risk creating isolated AI tools that don’t talk to each other,’ noted Dr. John Halamka, president of Mayo Clinic Platform. The tension between speed and scalability remains a central challenge.
VC Funding Validates the Model
The financial momentum is undeniable. Kleiner Perkins recently led a $50 million Series A for an AI scribe startup that partnered with UCSF through Converge. ‘Clinician co-development reduces time-to-market and improves adoption,’ said Mamoon Hamid, partner at Kleiner Perkins. Other accelerators—like Mayo Clinic Platform’s new cohort and Mass General Brigham’s program—are attracting similar investment. In total, health system AI investments surged 40% in 2024, reaching an estimated $7.2 billion, according to Rock Health data.
Contextualizing the Trend: Historical Patterns
The current wave of AI accelerators echoes earlier shifts in healthcare technology. Similar to the rise of electronic health records in the 2000s—when institutions like Kaiser Permanente pioneered internal development before commercial products matured—today’s inside-out AI approach reflects a push for bespoke solutions. However, unlike the EHR era, which eventually consolidated around a few dominant players, the AI landscape remains fragmented. A 2024 analysis in Health Affairs noted that 78% of health system AI projects are still in pilot phase, suggesting that scalability issues persist.
Moreover, the focus on clinician co-development is reminiscent of the user-centered design movement that transformed healthcare IT in the 2010s. Standards like FHIR have enabled APIs that make it easier for startups to integrate with existing systems. Yet, without regulatory push for interoperability, accelerators could inadvertently create data silos. ‘The lesson from the past is that innovation without standards leads to expensive integrations down the line,’ warned Dr. Blackford Middleton, chief informatics officer at Apervita. As health systems double down on AI accelerators, the next challenge will be balancing innovation with the cohesion that patients and providers ultimately need.
